Jon Napitupulu

Kura Oncology’s recent granting of stock options to 35 new employees, while seemingly routine, signals a strategic shift for...

Accumulus Synergy, a non-profit focused on regulatory innovation, has spun out its cloud-based regulatory connectivity platform, Accumulus Technologies, as...

XOMA Royalty Corporation’s acquisition of Hillevax for $1.95 per share in cash, plus a contingent value right (CVR), marks...

Lift Biosciences Secures €12M Grant to Advance “First-in-Class” Neutrophil Immunotherapy. Lift Biosciences has secured a €12 million grant from...

Full Alliance Group Signals Ambitious Growth Trajectory in Q2 2025 Results Full Alliance Group (FAGI) has announced preliminary unaudited...

Orchestra Biomed Secures $70M in Strategic Funding, Expanding Cardiovascular Pipeline and Partnerships Orchestra Biomed has secured $70 million in...

Poltreg Secures FDA Support for Registrational Trial in Pre-Symptomatic Type 1 Diabetes Poltreg, a Polish biotech specializing in T-regulatory...

Supernus Pharmaceuticals has finalized its acquisition of Sage Therapeutics, marking a significant shift in the CNS treatment landscape. This...

VedtechBio Research Pvt. Ltd. has significantly enhanced its AI-driven drug discovery platform, RxAgentAI™, claiming a halving of drug development...

Sanofi’s Q2 2025 results reveal a company navigating a complex landscape of patent expirations, new launches, and strategic acquisitions....